Skip Navigation
  • The MHH
  • Excellence
  • International office
  • Press
  • Emergency numbers
  • Patients & Visitors
    • Patients & Visitors
    • Admission as an emergency
    • Inpatient treatment
      • Inpatient treatment
      • Before your stay
      • During your stay
      • Ending your stay
    • Outpatient treatment
    • Important questions and answers
    • General information
      • General information
      • Dementia officer
      • Store passage
      • Teaching in the pediatric clinic
      • Directions
    • Patient Service Center PSC
      • Patient Service Center PSC
      • Contact
    • Patient advocate
  • Facilities & Departments
    • Facilities & Departments
    • Kliniken der MHH
    • Institutes of MHH
    • Clinical Departments and Institutes by MHH Centres
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
      • BeoNet register
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
      • Academic Career Development
      • Internal university performance promotion
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
      • Research Infrastructure
      • Research information system
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
    • Accident research
      • Accident research
      • What we do
      • You have been in contact with us
      • Science and research
      • Publications
  • Study & Teaching
    • Study & Teaching
    • Study programmes
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
    • Sayit anti-discrimination platform
    • MHH-Alumni e.V. - the alumni network
      • MHH-Alumni e.V. - the alumni network
      • Events
      • EM!L
      • MHH University Shop
      • Association
  • Career
    • Career
    • MHH training courses
    • MTR - Our diagnostics specialists with insight
    • Recruiting talent - for Nursing
      • Recruiting talent - for Nursing
      • Recruitment form
Welcome to the MHH Common content
Searched for "b.v". Found 422 results in 5 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • »
Page

B Cystic fibrosis center (cystic fibrosis) in children and adults

Relevance: 81%
 

Clinical trials with the participation of ZSE-B centers: List of clinical trials 2020 Publications You can download the current publications of this ZSE-B center as PDF files under the following link: [...] the outpatient clinic for adults are certified by the Cystic Fibrosis Association (Mukoviszidose e.V.). The CF Center was awarded the Christiane Herzog Prize in 2005 for special achievements in patient [...] organizations and self-help groups You can find more information under the following links: Mukoviszidose e.V., Bundesverband Cystische Fibrose (CF) To the website "Portal for rare diseases and orphan drugs" Orphanet

Page

Publication The Lancet

Relevance: 81%
 

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination SARS-CoV-2 Omicron XBB subvariants efficiently evade immunity from prior infection or vaccination, requiring vaccine adaptation [...] Within the frame of the ongoing CoCo Study, we analyzed the immunogenicity of an adapted vaccine, BNT162b2 Omicron XBB.1.5, which is currently used for booster vaccination. In this joint project together with [...] Rheumatology and Immunology) and AG Pöhlmann (German Primate Centre, Göttingen), we found that BNT162b2 Omicron XBB.1.5 vaccination resulted in potent neutralizing antibody responses against Omicron XBB

Page

B Center for Neurofibromatosis Type 1 and 2, Schwannomatosis and Von Hippel-Lindau Syndrome

Relevance: 81%
 

ZSE-B Center for Neurofibromatosis Type 1 and 2, Schwannomatosis and Von Hippel-Lindau Syndrome The description of the B Center for Neurofibromatosis Type 1 and 2, Schwannomatosis and Von Hippel-Lindau [...] Research Contact details B-Center for NF type 1 and 2, Schwannomatosis and Von Hippel-Lindau syndrome for adults : Hannover Medical School Clinical Department of Neurosurgery B-Center for NF Type 1 and [...] Clinical trials with the participation of ZSE-B centers: List of clinical trials 2020 Publications You can download the current publications of this ZSE-B center as PDF files under the following link:

Page

Publications

Relevance: 81%
 

Kern AE, Laferl V, Oldhafer F , Dong Y, Rumpf B, Vali M, Wiemann B , Ortmayr G, Brunner SE, Probst J, Aiad M, Jankoschek AS, Gramberger M, Tschoegl MM, Salem M, Surci N, Thonhauser R, Mazari V, Hoblaj T, [...] Fischer L, Kliem V, Vondran F , Sester U, Schneeberger S, Harth A, Kuypers D, Függer R, Arnol M, Christiaans M, Weinmann-Menke J, Krüger B, Hilbrands L, Banas B, Hakenberg O, Minnee R, Schwenger V, Heyne N, van [...] 31938833; PMCID: PMC7036059. Fischer K, Rieblinger B, Hein R, Sfriso R, Zuber J, Fischer A, Klinger B, Liang W, Flisikowski K, Kurome M, Zakhartchenko V, Kessler B, Wolf E, Rieben R, Schwinzer R , Kind A, Schnieke

Page

Self-help group

Relevance: 81%
 

Bladder cancer self-help group Hanover Logo of the ShB, Copyright: Selbsthilfe-Bund Blasenkrebs e.V. Do you have bladder cancer, are you looking for information, would you like to talk to fellow sufferers [...] to our bladder cancer self-help group at the MHH. Together with the Selbsthilfe-Bund Blasenkrebs e.V., the Clinical Department of Urology at MHH organizes a meeting every 1st Monday of the month from 17:00

Page

2017

Relevance: 81%
 

Kramer C, Ortiz-Brüchle N, Hilger N, Metzis V, Hiersche M, Tay SY, Tunningley R, Vij S, Courtney AD, Whittle B, Wühl E, Vester U, Hartleben B , Neuber S, Frank V, Little MH, Epting D, Papathanasiou P, Perkins [...] Dobbernack V, Kreimeyer H, Pankratz M, Flintrop M, Liebich A, Klesse S, Panagiota V, Stadler M, Wichmann M, Shahswar R, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Geffers R, Schlegelberger B, Göhring [...] Crit Care Med 2017; 196(8): e48-e51 Anwar SL , Krech T , Hasemeier B , Schipper E, Schweitzer N, Vogel A, Kreipe H , Buurman R, Skawran B, Lehmann U : hsa-mir-183 is frequently methylated and related to

Page

Publications 2015

Relevance: 81%
 

2015; VIII, 114 p. : graph. Fig. Sedlacek L, Graf B, Schwarz C, Albert F, Peter S, Wurstl B, Wagner S, Klotz M, Becker A, Haase G, Laniado G, Kahl B, Suerbaum S, Seibold M, Tintelnot K. Prevalence of [...] Lynen Jansen P, Malfertheiner P, Marth T, Meyer E, Mielke M, Moos V, von Müller L, Nattermann J, Nothacker M, Pox C, Reisinger ER, Salzberger B, Salzer HJF, Weber M, Weinke T, Suerbaum S, Lohse AW, Stallmach [...] arginine. PLoS One 2015; 10: e0136914. Hernandez PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hölscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A. In

Page

[Translate to Englisch:] A PHASE I/ RANDOMIZED PHASE II TRIAL TO ANALYSE SAFETY AND EFFICACY OF HUMAN SARS-COV-2-SPECIFIC T LYMPHOCYTE TRANSFER IN PATIENTS WITH COVID-19 IN NEED OF TREATMENT OR AT RISK OF SEVERE COVID-19

Relevance: 81%
 

Schmidt JJ, Li Y, Welte T, Maecker-Kolhoff B, Martens J, Berger MM, Lobenwein C, Stankov MV, Cornberg M, David S, Behrens GMN, Witzke O, Blasczyk R, Eiz-Vesper B.Immunity. 2021 Feb 9;54(2):340-354.e6. doi: [...] immuni.2021.01.008. Rapid manufacturing of highly cytotoxic clinical-grade SARS-CoV-2-specific T cell products covering SARS-CoV-2 and its variants for adoptive T cell therapy Agnes Bonifacius, Sabine Tisc [...] Stankov MV, Mausberg P, Tischer-Zimmermann S, Gödecke N, Kalinke U, Behrens GMN, Blasczyk R, Eiz-Vesper B.Front Med (Lausanne). 2021 Nov 25;8:770381. doi: 10.3389/fmed.2021.770381. eCollection 2021.PMID: 34901085

Page

Publications

Relevance: 81%
 

Krähling V, Bernhardt G, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Hammerschmidt SI, Förster R. BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination [...] Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Förster R, Behrens GMN. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nat Med. 2021 Jul 14. [...] idt SI, Thurm C, Bošnjak B, Bernhardt G, Reinhold A, Willenzon S, Ritter C, Reinhold D, Schraven B, Förster R. Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous

Page

Publications 2016

Relevance: 81%
 

Pilot Study. Healthcare 2016; 4 (3): doi: 10.3390/healthcare4030064 Seijas V, Lugo LH, Cano B, Escobar LM, Quintero C, Nugraha B, Gutenbrunner C. Understanding Community-Based Rehabilitation and the role [...] 2016; 3: 46-51 Defi IR and Nugraha B. Ada apa dengan disabilitas (AADD). Pikiran Rakyat. 3 December 2016 (Newspaper article in Indonesian) Gutenbrunner C, Fialka Moser V. The specialty of physical and r [...] Publications 2016 Publications in scientific journals (peer-reviewed) Blumenthal M, Geng V, Egen C, Gutenbrunner C. Paraplegia in Germany - Research data on the health, care and living situation of people

  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • »
Imprint Intranet Contact Privacy Accessibility

Information about

Excellence Strategy Academic career development Blood donation service Equality MHH Quality Report MHH-Alumni e.V. Baby gallery

Service

Patient Service Center Patient data requests GDPR Patient Advocate Feedback and complaint management ProBeweis - Confidential forensic evidence Campus life Fit for Work and Life

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2026 Medizinische Hochschule Hannover
Nach oben scrollen